Literature DB >> 5437304

Effect of formalin, beta-propiolactone, merthiolate, and ultraviolet light upon influenza virus infectivity chicken cell agglutination, hemagglutination, and antigenicity.

M A Goldstein, N M Tauraso.   

Abstract

Four strains of influenza virus were treated with Formalin, Merthiolate, Merthiolate and Formalin, ultraviolet light, and beta-propiolactone (BPL) for 18, 48, and 72 hr. Infectivity, chicken cell agglutination (CCA), hemagglutination (HA), and antigenicity determinations were made. Except for Merthiolate, each method of inactivation was equally effective in reducing infectivity. Loss of infectivity was related to length of treatment. CCA determinations were higher for all treated groups except for BPL-treated samples; these had lower determinations. BPL treatment also lowered the HA titer. Antigenicity was lessened by BPL treatment and by Merthiolate and Formalin treatment. Generally, the length of inactivation up to 72 hr did not affect CCA, HA, or antigenicity determinations. For the most part, there was no significant differences in the reactivity of the four strains.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5437304      PMCID: PMC376670          DOI: 10.1128/am.19.2.290-294.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  9 in total

1.  INACTIVATION OF THE INFECTIVITY OF VIRAL HEMAGGLUTINATING ANTIGENS WITH THE USE OF BETAPRONE.

Authors:  J L SEVER; G A CASTELLANO; W PELON; R J HUEBNER; F WOLMAN
Journal:  J Lab Clin Med       Date:  1964-12

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  A review of theoretical, experimental, and practical considerations in the use of formaldehyde for the inactivation of poliovirus.

Authors:  J E SALK; J B GORI
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

4.  Investigations of the use of beta-propiolactone in virus inactivation.

Authors:  G A LOGRIPPO
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

5.  The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity.

Authors:  J R POLLEY; M M GUERIN
Journal:  Can J Microbiol       Date:  1957-10       Impact factor: 2.419

6.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

7.  Experiences in the production of poliovirus vaccines.

Authors:  I W McLEAN; A R TAYLOR
Journal:  Prog Med Virol       Date:  1958

8.  Antigenicity of combined beta-propiolactone and ultraviolet inactivated virus vaccines.

Authors:  G A LOGRIPPO
Journal:  J Immunol       Date:  1958-03       Impact factor: 5.422

9.  Vaccination against influenza.

Authors:  T FRANCIS
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

  9 in total
  19 in total

1.  Validation of normal human bronchial epithelial cells as a model for influenza A infections in human distal trachea.

Authors:  A Sally Davis; Daniel S Chertow; Jenna E Moyer; Jon Suzich; Aline Sandouk; David W Dorward; Carolea Logun; James H Shelhamer; Jeffery K Taubenberger
Journal:  J Histochem Cytochem       Date:  2015-01-20       Impact factor: 2.479

2.  Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.

Authors:  Benjamin K Quintel; Archana Thomas; Danae E Poer DeRaad; Mark K Slifka; Ian J Amanna
Journal:  Vaccine       Date:  2018-12-31       Impact factor: 3.641

3.  Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling.

Authors:  Marcel Jonges; Wai Ming Liu; Erhard van der Vries; Ronald Jacobi; Inge Pronk; Claire Boog; Marion Koopmans; Adam Meijer; Ernst Soethout
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

4.  Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

Authors:  Nayana Prabhu; Mookkan Prabakaran; Hui-Ting Ho; Sumathy Velumani; Jia Qiang; Michael Goutama; Jimmy Kwang
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

5.  Effect of -propiolactone on Sendai virus.

Authors:  M A Wainberg; R N Hjorth; C Howe
Journal:  Appl Microbiol       Date:  1971-10

6.  Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody.

Authors:  Qigai He; Sumathy Velumani; Qingyun Du; Chee Wee Lim; Fook Kheong Ng; Ruben Donis; Jimmy Kwang
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

7.  Surface modifications of influenza proteins upon virus inactivation by β-propiolactone.

Authors:  Yi-Min She; Keding Cheng; Aaron Farnsworth; Xuguang Li; Terry D Cyr
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

Review 8.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Single domain antibody multimers confer protection against rabies infection.

Authors:  Bhargavi M Boruah; Dawei Liu; Duan Ye; Tie-Jun Gu; Chun-Lai Jiang; Mingsheng Qu; Edward Wright; Wei Wang; Wen He; Changzhen Liu; Bin Gao
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  An Impedance Aptasensor with Microfluidic Chips for Specific Detection of H5N1 Avian Influenza Virus.

Authors:  Jacob Lum; Ronghui Wang; Billy Hargis; Steve Tung; Walter Bottje; Huaguang Lu; Yanbin Li
Journal:  Sensors (Basel)       Date:  2015-07-29       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.